Xiu Qing Wang
Overview
Explore the profile of Xiu Qing Wang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
41
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hutspardol S, Borja T, Kroeker J, Wang X, Mi J, Zamar D, et al.
Transfus Med
. 2025 Jan;
PMID: 39865389
Objectives: Trauma-induced coagulopathy (TIC) can be fatal but preventable if recognised early. With emerging uses of rotational thromboelastometry (ROTEM) to guide transfusions in trauma, patient outcomes with TIC-defined by initial...
2.
Shopsowitz K, Wang X, Soleimani M, Hudoba M, Chen L, McGinnis E
Lancet Oncol
. 2023 Aug;
24(8):e355.
PMID: 37541281
No abstract available.
3.
Wang X, Tessier-Cloutier B, Saunders J, Harvey M, Armstrong L, Ng T, et al.
Appl Immunohistochem Mol Morphol
. 2023 Apr;
31(5):304-310.
PMID: 37036408
Tumors of the central nervous system (CNS) in pediatric patients have undergone significant diagnostic refinement through the use of immunohistochemistry (IHC) and molecular techniques. The utility of these novel IHC...
4.
5.
Klaric K, Riaz N, Asleh K, Wang X, Atalla T, Strickland S, et al.
Histopathology
. 2021 Nov;
80(3):589-597.
PMID: 34725848
Aims: Basal-like breast cancer is an aggressive molecular subtype associated with younger age and early relapse. Most cases lack expression of oestrogen receptor (ER), progesterone receptor, and human epidermal growth...
6.
Saunders J, Ingley K, Wang X, Harvey M, Armstrong L, Ng T, et al.
Pediatr Dev Pathol
. 2019 Aug;
23(2):132-138.
PMID: 31403913
Malignant rhabdoid tumors and atypical teratoid/rhabdoid tumors of the central nervous system are primitive malignancies associated with a poor prognosis. These tumors have previously been characterized by inactivation of the...
7.
Laporte A, Poulin N, Barrott J, Wang X, Lorzadeh A, Vander Werff R, et al.
Mol Cancer Ther
. 2017 Sep;
16(12):2656-2667.
PMID: 28878027
Conventional cytotoxic therapies for synovial sarcoma provide limited benefit, and no drugs specifically targeting the causative SS18-SSX fusion oncoprotein are currently available. Histone deacetylase (HDAC) inhibition has been shown in...
8.
Sheffield B, Kos Z, Asleh-Aburaya K, Wang X, Leung S, Gao D, et al.
Breast Cancer Res Treat
. 2016 Feb;
155(3):483-90.
PMID: 26846986
The estrogen receptor (ER) is a key predictive biomarker in the treatment of breast cancer. There is uncertainty regarding the use of hormonal therapy in the setting of weakly positive...